News

The Evercode Whole Transcriptome Mega represents the most scalable and highest resolution single-cell platform to date Seattle, WA, October 20, 2021 Today at the annual American Society for Human Genetics meeting, Parse Biosciences, a company providing researchers with single-cell sequencing solutions, announced the launch of the most scalable single-cell RNA-seq solution on the market.  The Evercode […]

Seattle, WA, October 11, 2021 Parse Biosciences, today announced a partnership with Decode Science to provide Parse’s single-cell RNA-seq solution to the Australian and New Zealand markets. Under an agreement between the parties, Decode Science has been appointed a distributor of the Parse product portfolio for Australia and New Zealand. Decode Science will provide customer service, technical […]

Now commercially available, the Whole Transcriptome Kit enables researchers in neuroscience, immunology, oncology, as well as other areas of scientific study, to achieve industry-leading detail on cell types and subtypes Seattle, WA, February 18, 2021 Parse Biosciences., a company providing researchers with scalable and flexible single cell sequencing solutions, today announced the launch of their […]

https://www.genomeweb.com/business-news/split-biosciences-rebrands-parse-biosciences-raises-7m-series-financing#.YetHLP7MKUl

https://www.geekwire.com/2021/seattle-biotech-startup-split-biosciences-raises-7m-changes-name-parse-biosciences/

As adoption of scRNA-seq in industry and academia accelerates, Parse Biosciences (formerly Split Bio) offers the most flexible and scalable single cell sequencing kit, no custom instrument needed Seattle, WA, January 26, 2021 Split Biosciences, a company providing researchers scalable and flexible single cell sequencing solutions, today announced $7M in Series A funding. The funding […]

https://www.biorxiv.org/content/10.1101/2020.06.30.174391v1.abstract